MRNA Moderna
Nasdaq · SEC CIK 1682852 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $64.63M 14 sales by 6 insiders
- Filings on record
- 574 since 2021-07-02, latest 2026-09-16 16:48
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bancel Stephane | CEO, Dir | — | $28.72M |
| Hoge Stephen | Pres | — | $28.43M |
| Mock James M | CFO | — | $4.69M |
| Klinger Shannon Thyme | CLO | — | $1.39M |
| AFEYAN NOUBAR | Dir | — | $1.14M |
| Hussain Abbas | Dir | — | $278.9K |
| Horning Sandra | Dir | — | — |
| NABEL ELIZABETH G | Dir | — | — |
| Rubenstein David M. | Dir | — | — |
| Nader Francois | Dir | — | — |
Transactions 1,002
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-20 | 2023-01-18+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| 2023-01-20 | 2023-01-18 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $200.20 | -10.0K | 2.25M | -0.4% | -$2.00M | |
| DM | 2023-01-13 | 2023-01-11+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-01-13 | 2023-01-11+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $185.26 | -80.0K | 5.43M | -1% | -$14.82M |
| 2023-01-13 | 2023-01-11 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $188.57 | -10.0K | 2.26M | -0.4% | -$1.89M | |
| 2023-01-06 | 2023-01-04 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $182.15 | -10.0K | 2.27M | -0.4% | -$1.82M | |
| DM | 2023-01-06 | 2023-01-04+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $175.84 | -80.0K | 5.41M | -1% | -$14.07M |
| DM | 2023-01-06 | 2023-01-04+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| D | 2022-12-30 | 2022-12-28 | MRNA | Andres Juan | See remarks | S - Sale+OE | $180.00 | -2,000 | 12.8K | -14% | -$360.0K |
| D | 2022-12-30 | 2022-12-28 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 14.8K | +16% | +$41.9K |
| DM | 2022-12-30 | 2022-12-28+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $178.42 | -80.0K | 5.43M | -1% | -$14.27M |
| DM | 2022-12-30 | 2022-12-28+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DI | 2022-12-30 | 2022-12-29 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $178.19 | -10.0K | 6.56M | -0.2% | -$1.78M |
| 2022-12-23 | 2022-12-21 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $201.70 | -10.0K | 2.28M | -0.4% | -$2.02M | |
| D | 2022-12-23 | 2022-12-21 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 14.8K | +16% | +$41.9K |
| D | 2022-12-23 | 2022-12-21 | MRNA | Andres Juan | See remarks | S - Sale+OE | $201.70 | -2,000 | 12.8K | -14% | -$403.4K |
| DM | 2022-12-23 | 2022-12-21+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2022-12-23 | 2022-12-21+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $206.20 | -80.0K | 5.45M | -1% | -$16.50M |
| DI | 2022-12-23 | 2022-12-22 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $209.82 | -10.0K | 6.57M | -0.2% | -$2.10M |
| D | 2022-12-16 | 2022-12-14 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 14.8K | +16% | +$41.9K |
| D | 2022-12-16 | 2022-12-14 | MRNA | Andres Juan | See remarks | S - Sale+OE | $195.00 | -2,000 | 12.8K | -14% | -$390.0K |
| DM | 2022-12-16 | 2022-12-14+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2022-12-16 | 2022-12-14+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $208.76 | -80.0K | 5.41M | -1% | -$16.70M |
| DI | 2022-12-16 | 2022-12-15 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $207.88 | -10.0K | 6.58M | -0.2% | -$2.08M |
| 2022-12-16 | 2022-12-14 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $195.00 | -10.0K | 2.29M | -0.4% | -$1.95M | |
| 2022-12-09 | 2022-12-07 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $172.16 | -10.0K | 2.30M | -0.4% | -$1.72M | |
| D | 2022-12-09 | 2022-12-07 | MRNA | Andres Juan | See remarks | S - Sale+OE | $172.16 | -2,000 | 12.8K | -14% | -$344.3K |
| D | 2022-12-09 | 2022-12-07 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 14.8K | +16% | +$41.9K |
| DM | 2022-12-09 | 2022-12-07+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $180.47 | -80.0K | 5.41M | -1% | -$14.44M |
| DI | 2022-12-09 | 2022-12-08 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $179.12 | -10.0K | 6.59M | -0.2% | -$1.79M |
| DM | 2022-12-09 | 2022-12-07+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| D | 2022-12-09 | 2022-12-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | +1,139 | 5,262 | +28% | $0 |
| D | 2022-12-09 | 2022-12-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $179.15 | -490 | 4,772 | -9% | -$87.8K |
| 2022-12-02 | 2022-11-30 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $173.52 | -10.0K | 2.31M | -0.4% | -$1.74M | |
| D | 2022-12-02 | 2022-11-30 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 14.8K | +16% | +$41.9K |
| D | 2022-12-02 | 2022-11-30 | MRNA | Andres Juan | See remarks | S - Sale+OE | $173.52 | -2,000 | 12.8K | -14% | -$347.0K |
| DM | 2022-12-02 | 2022-11-30+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $176.64 | -80.0K | 5.43M | -1% | -$14.13M |
| DI | 2022-12-02 | 2022-12-01 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $173.41 | -10.0K | 6.60M | -0.2% | -$1.73M |
| DM | 2022-12-02 | 2022-11-30+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| D | 2022-11-30 | 2022-11-28 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | +1,808 | 13.6K | +15% | $0 |
| D | 2022-11-30 | 2022-11-29 | MRNA | Andres Juan | See remarks | S - Sale+OE | $173.80 | -814 | 12.8K | -6% | -$141.5K |
| D | 2022-11-30 | 2022-11-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $173.80 | -1,085 | 1.63M | -0.1% | -$188.6K |
| D | 2022-11-30 | 2022-11-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +2,410 | 1.63M | +0.1% | $0 |
| DI | 2022-11-28 | 2022-11-25 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $175.01 | -10.0K | 6.61M | -0.2% | -$1.75M |
| DM | 2022-11-28 | 2022-11-25 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $176.04 | -40.0K | 5.42M | -0.7% | -$7.04M |
| D | 2022-11-28 | 2022-11-25 | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +40.0K | 5.45M | +0.7% | +$39.6K |
| D | 2022-11-25 | 2022-11-23 | MRNA | Andres Juan | See remarks | S - Sale+OE | $178.01 | -2,000 | 11.8K | -14% | -$356.0K |
| D | 2022-11-25 | 2022-11-23 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 13.8K | +17% | +$41.9K |
| DM | 2022-11-25 | 2022-11-23 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $176.20 | -40.0K | 5.41M | -0.7% | -$7.05M |
| D | 2022-11-25 | 2022-11-23 | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +40.0K | 5.45M | +0.7% | +$39.6K |
| 2022-11-25 | 2022-11-23 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $178.01 | -10.0K | 2.32M | -0.4% | -$1.78M | |
| 2022-11-18 | 2022-11-16 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $184.25 | -10.0K | 2.33M | -0.4% | -$1.84M | |
| DM | 2022-11-18 | 2022-11-16+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $183.52 | -80.0K | 5.41M | -1% | -$14.68M |
| DM | 2022-11-18 | 2022-11-16+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DI | 2022-11-18 | 2022-11-17 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $181.33 | -10.0K | 6.62M | -0.2% | -$1.81M |
| D | 2022-11-18 | 2022-11-16 | MRNA | Andres Juan | See remarks | S - Sale+OE | $184.25 | -2,000 | 11.8K | -14% | -$368.5K |
| D | 2022-11-18 | 2022-11-16 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 13.8K | +17% | +$41.9K |
| DM | 2022-11-14 | 2022-11-09 | MRNA | Andres Juan | See remarks | M - OptEx | $17.19 | +2,435 | 14.0K | +21% | +$41.9K |
| DM | 2022-11-14 | 2022-11-09+ | MRNA | Andres Juan | See remarks | S - Sale+OE | $162.77 | -2,192 | 11.8K | -16% | -$356.8K |
| D | 2022-11-14 | 2022-11-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $165.59 | -231 | 1.63M | -0.0% | -$38.3K |
| D | 2022-11-14 | 2022-11-09 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +522 | 1.63M | +0.0% | $0 |
| DI | 2022-11-14 | 2022-11-10 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $164.43 | -10.0K | 6.63M | -0.2% | -$1.64M |
| DM | 2022-11-14 | 2022-11-09+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2022-11-14 | 2022-11-09+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $165.65 | -80.0K | 5.41M | -1% | -$13.25M |
| 2022-11-10 | 2022-11-09 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $162.50 | -10.0K | 2.34M | -0.4% | -$1.62M | |
| D | 2022-11-08 | 2022-11-04 | MRNA | Burton Paul | Chief Medical Off | M - OptEx | $0.00 | +402 | 1,146 | +54% | $0 |
| D | 2022-11-08 | 2022-11-07 | MRNA | Burton Paul | Chief Medical Off | S - Sale+OE | $158.68 | -192 | 954 | -17% | -$30.5K |
| 2022-11-04 | 2022-11-02 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $154.20 | -10.0K | 2.35M | -0.4% | -$1.54M | |
| D | 2022-11-04 | 2022-11-02 | MRNA | Andres Juan | See remarks | S - Sale+OE | $154.20 | -2,000 | 11.6K | -15% | -$308.4K |
| D | 2022-11-04 | 2022-11-02 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 13.6K | +17% | +$41.9K |
| DM | 2022-11-04 | 2022-11-02+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $149.96 | -80.0K | 5.41M | -1% | -$12.00M |
| DI | 2022-11-04 | 2022-11-03 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $138.61 | -10.0K | 6.64M | -0.2% | -$1.39M |
| DM | 2022-11-04 | 2022-11-02+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| D | 2022-10-31 | 2022-10-28 | MRNA | Andres Juan | See remarks | S - Sale+OE | $150.00 | -4,000 | 11.6K | -26% | -$600.0K |
| DM | 2022-10-31 | 2022-10-28 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +4,000 | 13.6K | +42% | +$83.7K |
| 2022-10-28 | 2022-10-26 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $137.25 | -10.0K | 2.36M | -0.4% | -$1.37M | |
| DM | 2022-10-28 | 2022-10-26+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $143.06 | -80.0K | 5.41M | -1% | -$11.45M |
| DI | 2022-10-28 | 2022-10-27 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $143.38 | -10.0K | 6.65M | -0.2% | -$1.43M |
| DM | 2022-10-28 | 2022-10-26+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| 2022-10-21 | 2022-10-19 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $132.50 | -10.0K | 2.37M | -0.4% | -$1.32M | |
| DM | 2022-10-21 | 2022-10-19+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2022-10-21 | 2022-10-19+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $123.07 | -80.0K | 5.41M | -1% | -$9.85M |
| DI | 2022-10-21 | 2022-10-20 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $122.94 | -10.0K | 6.66M | -0.1% | -$1.23M |
| 2022-10-14 | 2022-10-12 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $135.36 | -10.0K | 2.38M | -0.4% | -$1.35M | |
| DM | 2022-10-14 | 2022-10-12+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $132.77 | -80.0K | 5.45M | -1% | -$10.62M |
| DM | 2022-10-14 | 2022-10-12+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DI | 2022-10-14 | 2022-10-13 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $126.51 | -10.0K | 6.67M | -0.1% | -$1.27M |
| DM | 2022-10-07 | 2022-10-05+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2022-10-07 | 2022-10-05+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $124.51 | -80.0K | 5.41M | -1% | -$9.96M |
| DI | 2022-10-07 | 2022-10-06 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $124.52 | -10.0K | 6.68M | -0.1% | -$1.25M |
| 2022-10-07 | 2022-10-05 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $122.40 | -10.0K | 2.39M | -0.4% | -$1.22M | |
| DM | 2022-09-30 | 2022-09-28+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2022-09-30 | 2022-09-28+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $119.92 | -80.0K | 5.41M | -1% | -$9.59M |
| DI | 2022-09-30 | 2022-09-29 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $119.82 | -10.0K | 6.69M | -0.1% | -$1.20M |
| 2022-09-30 | 2022-09-28 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $123.58 | -10.0K | 2.40M | -0.4% | -$1.24M | |
| DM | 2022-09-23 | 2022-09-21+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2022-09-23 | 2022-09-21+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $126.91 | -80.0K | 5.42M | -1% | -$10.15M |
| DI | 2022-09-23 | 2022-09-22 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $124.20 | -10.0K | 6.70M | -0.1% | -$1.24M |
| 2022-09-23 | 2022-09-21 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $130.37 | -10.0K | 2.41M | -0.4% | -$1.30M | |
| 2022-09-16 | 2022-09-14 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $134.00 | -10.0K | 2.42M | -0.4% | -$1.34M |
Purchase Sale Sale after option exercise All abbreviations